CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
企業コードCBLL
会社名CeriBell Inc
上場日Oct 11, 2024
設立日2014
最高経営責任者「CEO」Ms. Xingjuan (Jane) Chao, Ph.D.
従業員数281
証券種類Ordinary Share
決算期末Oct 11
本社所在地360 N. Pastoria Avenue
都市SUNNYVALE
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号94085
電話番号18004360826
ウェブサイトhttps://ceribell.com/
企業コードCBLL
上場日Oct 11, 2024
設立日2014
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし